By Dr. Claire Craig
Where are the 25,706 patients missing from the Pfizer data?
There’s a *big* gap between Pfizer’s claims and what their latest data release shows.
Let’s start with their paper which makes a simple claim in the abstract:
“At the data cut-off date of October 9, a total of 37,706 participants had a median of at least 2 months of safety data available after the second dose and contributed to the main safety data set.”
